Identifying epigenetic vulnerabilities in peripheral t-cell lymphomas
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2211027
- Recipient
-
The Trustees Of Columbia University In The City Of New York UEI QHF5ZZ114M72
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $567,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- New York, NY 10032, USA
Award details come from USAspending.gov.
About this award
The Trustees of Columbia University in New York City will receive $567,000 from the Department of the Army Medical Command under a three-year Project Grant award to identify epigenetic vulnerabilities in peripheral T-cell lymphomas. The grant period runs from September 1, 2022 through August 31, 2025.
The funding supports research conducted under the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health through innovative biomedical research solutions. Specifically, Columbia University researchers will investigate epigenetic factors that could be targeted for new treatment approaches to peripheral T-cell lymphomas, advancing the program's goal of developing medical solutions for service members and the general public.
Quick answers
Who received award W81XWH2211027?
W81XWH2211027 was awarded to The Trustees Of Columbia University In The City Of New York by Medical Command (Department of the Army) on September 1, 2022.
How much is award W81XWH2211027 worth?
$567,000 has been obligated on W81XWH2211027.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award